[1] LANGESKOV-CHRISTENSEN M, FRANZÉN E, GRØNDAHL HVID L, et al. Exercise as medicine in Parkinson’s disease[J]. J Neurol Neurosurg Psychiatry, 2024, 95(11):1077-1088. [2] GALLAGHER J, GOCHANOUR C, CASPELL-GARCIA C, et al. Long-term dementia risk in parkinson disease[J]. Neurology, 2024, 103(5):e209699. [3] KUMARAN S P, GURRAM S L, VISWAMITRA S, et al. Utility of DTI (diffusion tensor imaging) metrics to study microstructural changes of trigeminal nerve in patients with trigeminal neuralgia (TN)[J]. Neurol India, 2022, 70(1):270-274. [4] 郭龙军, 梁长华. 磁共振弥散张量成像在帕金森病诊断与定量分析中的应用价值[J]. 中风与神经疾病杂志, 2020, 37(10):900-903. [5] HÖGLINGER G, German Parkinsin’s Guidelines Committee, TRENKWALDER C. Diagnosis and treatment of Parkinson’s disease (guideline of the German Society for Neurology)[J]. Neurol Res Pract, 2024, 6(1):30. [6] YUAN X F, ZHANG Y, ZHANG Y, et al. Reliability and validity of the Brief Assessmentof Impaired Cognition (Chinese version) for stroke patients[J]. Appl Neuropsychol Adult, 2023, 30(1):27-33. [7] MORRIS H R, SPILLANTINI M G, SUE C M, et al. The pathogenesis of Parkinson’s disease[J]. Lancet, 2024, 403(10423):293-304. [8] 孙婷, 朱建兵, 马清, 等. MRI检查对帕金森病患者认知功能障碍继发痴呆的预测价值研究[J]. 中国医学装备, 2024, 21(12):83-87. [9] TANTIK PAK A, NACAR DOGAN S, SENGUL Y. Structural integrity of corpus callosum in patients with migraine:a diffusion tensor imaging study[J]. Acta Neurol Belg, 2023, 123(2):385-390. [10] 耿磊, 王锐, 张照婷, 等. 弥散张量成像对帕金森病前驱期的诊断价值[J]. 实用医学杂志, 2023, 39(21):2843-2849. [11] BECERRA-LAPARRA I, CORTEZ-CONRADIS D, GARCIA-LAZARO H G, et al. Radial diffusivity is the best global biomarker able to discriminate healthy elders, mild cognitive impairment, and Alzheimer’s disease:a diagnostic study of DTI-derived data[J]. Neurol India, 2020, 68(2):427-434. [12] NIGRO P, CHIAPPINIELLO A, SIMONI S, et al. Changes of olfactory tract in Parkinson’s disease:a DTI tractography study[J]. Neuroradiology, 2021, 63(2):235-242. [13] BOHNEN N I, ALBIN R L, MÜLLER M L T M, et al. Frequency of cholinergic and caudate nucleus dopaminergic deficits across the predemented cognitive spectrum of Parkinson disease and evidence of interaction effects[J]. JAMA Neurol, 2015, 72(2):194-200. [14] KARIMI B, SILWAL P, BOOTH S, et al. Schizophrenia-associated LRRTM1 regulates cognitive behavior through controlling synaptic function in the mediodorsal thalamus[J]. Mol Psychiatry, 2021, 26(11):6912-6925. [15] AARSLAND D, BATZU L, HALLIDAY G M, et al. Parkinson disease-associated cognitive impairment[J]. Nat Rev Dis Primers, 2021, 7(1):47. [16] LI L, TANG S, HAO B, et al. Early detection and management of cognitive impairment in Parkinson’s disease:a predictive model approach[J]. Brain Behav, 2025, 15(3):e70423. [17] 杨一帆, 高峰, 柳华, 等. 老年帕金森病病人外周血ApoA1/HDL、血尿酸水平与认知功能的关系[J]. 中西医结合心脑血管病杂志, 2023, 21(13):2474-2478. [18] MIJAILOVIC N R, VESIC K, BOROVCANIN M M. The influence of serum uric acid on the brain and cognitive dysfunction[J]. Front Psychiatry, 2022, 13:828476. [19] 王菲, 张娟利. 应用血清RANTES、MIF构建帕金森病并发认知功能障碍预测模型的价值分析[J]. 中风与神经疾病杂志, 2023, 40(6):544-548. |